Polymetaphosphate Lavage for Dissolving Joint Crystals
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for microcrystalline arthropathies, such as chondrocalcinosis and hydroxyapatite deposition, are largely symptomatic and fail to durably address the persistence of calcium pyrophosphate dihydrate (CPPD) or hydroxyapatite (HAP) crystals, leading to ongoing inflammatory issues, with existing therapies like arthrocentesis and nonsteroidal anti-inflammatory drugs offering limited long-term solutions.
Innovation Solution
The use of polymetaphosphates, specifically sodium hexametaphosphate, in a continuous or step-wise articular lavage procedure, which combines mechanical washing with chelating and solubilizing properties to effectively dissolve CPPD and HAP crystals, enhancing the removal of calcific deposits and associated pain symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If arthrocentesis and nonsteroidal anti-inflammatory drugs are used for treatment, then symptomatic relief is achieved, but the crystals persist and cause ongoing inflammation
Solution Approach 1:
The patent converts the harmful crystalline deposits into beneficial dissolved ions. Polymetaphosphates chemically interact with CPPD and HAP crystals, solubilizing them and converting the harmful solid crystal form into beneficial dissolved calcium and phosphate ions that can be naturally utilized by the body's metabolic processes.
Solution Approach 2:
The patent changes the chemical and physical parameters of the crystal deposits. By introducing polymetaphosphates, the treatment alters the solubility parameters and chemical composition of the deposits, transforming insoluble crystal structures into soluble ionic forms that can be removed from the joint through lavage.
2Quantity of substance
If static lavage with polymetaphosphates is used, then some crystal solubilization occurs, but the mechanical removal effect is insufficient
Solution Approach 1:
The patent merges two distinct mechanisms into a single therapeutic approach: the chemical solubilization action of polymetaphosphates and the mechanical removal action of dynamic lavage. This combination ensures that crystals are both chemically dissolved and physically flushed from the joint cavity, achieving synergistic enhancement of treatment efficacy.
Solution Approach 2:
The patent employs hydraulic principles through the use of dynamic lavage systems that utilize fluid flow and pressure to mechanically remove crystal deposits from the joint. The continuous circulation of lavage solution creates hydrodynamic forces that enhance the physical removal of solubilized and non-solubilized crystal material.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described method significantly increases the solubilization of calcium pyrophosphate and hydroxyapatite crystals, providing greater pain relief and more effective removal of calcific deposits compared to static lavage methods, with sodium hexametaphosphate achieving up to 52.5% solubilization of CPPD and 19.1% of HAP in continuous lavage, surpassing the 30.6% and 10.4% achieved in static lavage.
Implementation Method 1
The use of polymetaphosphates, specifically sodium hexametaphosphate, in a continuous or step-wise articular lavage procedure, which combines mechanical washing with chelating and solubilizing properties to effectively dissolve CPPD and HAP crystals
Implementation Method 2
The use of polymetaphosphates, specifically sodium hexametaphosphate, in a continuous or step-wise articular lavage procedure, which combines mechanical washing with chelating and solubilizing properties to effectively dissolve CPPD and HAP crystals
Data Source
AI summary
The invention relates to the use of polymetaphosphates for intra-articular application for the treatment of microcrystalline arthropathies. The preparation comprises a diluent water solution and a linear or cyclic polymetaphosphate in lyophilized powder, in which the volume of diluent solution and the weight/volume ratio of lyophilized polymetaphosphate powder and diluent solution are comprised within defined fields, and the treatment is carried out by step-wise lavage, i.e. using in succession a plurality of defined portions of reconstituted solution for a joint lavage, or by continuous lavage.